BackSeres Therapeutics Overview

Seres Therapeutics Current Cash

Track Seres Therapeutics's current cash ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$15.59M
↓ 65.64% YoYΔ $-29.79M vs prior year quarter

Peer trimmed avg / median

Loading

Seres Therapeutics Current Cash History

Loading

Seres Therapeutics vs. peers: Current Cash Comparison

Loading

Seres Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Seres Therapeutics (MCRB) FAQ

The latest current cash for MCRB is $16M as of June 2026. That compares with $45M in the prior-year period — down 65.6% year over year. Investors often review this figure alongside Seres Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, MCRB's current cash moved from $45M to $16M — a 65.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Seres Therapeutics's operating scale or balance-sheet position.

A current cash figure of $16M for MCRB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MCRB's current cash ($16M), review year-over-year change from $45M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Seres Therapeutics's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.